Health
AstraZeneca U.S. COVID-19 vaccine trial results likely in late-January, says health official – Reuters
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief…
By Reuters Staff
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. governments Operation Warp Speed program said on Wednesday.
The British drugmaker…
-
General23 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General18 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News22 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Noosa News21 hours agoNoosa Open Studios 2025 Art Trail kicks off today